ArticleFrontiers in oncology2025

Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response.

Guanlin Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.